Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gilbert

Showing results (231-240 of 247) with videos related to

Pageof 25
Sort By:
Plos One|February 18, 2014
Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian settingJulio S G Montaner, Viviane D Lima, P Richard Harrigan, et al.
The Lancet. Oncology|May 5, 2012
Phase 2 trial design in neuro-oncology revisited: a report from the RANO groupEvanthia Galanis, Wenting Wu, Timothy Cloughesy, et al.
Journal of the American Heart Association|October 16, 2013
Abnormal calcium cycling and cardiac arrhythmias associated with the human Ser96Ala genetic variant of histidine-rich calcium-binding proteinVivek P Singh, Jack Rubinstein, Demetrios A Arvanitis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 23, 2026
Trends in the incidence of HPV-associated anal cancer by risk group, 1990-2019: A population-based cohort study in British Columbia, CanadaAmit K Gupta, Aidan Ablona, Theodora B Consolacion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survivalYanhong Liu, Sanjay Shete, Carol J Etzel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with afliberceptJohn F de Groot, Yuji Piao, Hai Tran, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Process monitoring of an HIV treatment as prevention program in British Columbia, CanadaLillian Lourenço, Viviane D Lima, Kate Heath, et al.
Journal of Neuro-Oncology|February 26, 2020
The prevalence of altered body image in patients with primary brain tumors: an understudied populationLindsay Rowe, Elizabeth Vera, Alvina Acquaye, et al.
Clinical Epidemiology|September 15, 2018
Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individualsZahid A Butt, Nabin Shrestha, Dionne Gesink, et al.
Journal of Neuro-Oncology|July 20, 2002
An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitisKurt A Jaeckle, Tracy Batchelor, Steven J O'Day, et al.
Pageof 25

Showing results (231-240 of 247) with videos related to

Sort By:
Pageof 25
Plos One|February 18, 2014
Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian settingJulio S G Montaner, Viviane D Lima, P Richard Harrigan, et al.
The Lancet. Oncology|May 5, 2012
Phase 2 trial design in neuro-oncology revisited: a report from the RANO groupEvanthia Galanis, Wenting Wu, Timothy Cloughesy, et al.
Journal of the American Heart Association|October 16, 2013
Abnormal calcium cycling and cardiac arrhythmias associated with the human Ser96Ala genetic variant of histidine-rich calcium-binding proteinVivek P Singh, Jack Rubinstein, Demetrios A Arvanitis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 23, 2026
Trends in the incidence of HPV-associated anal cancer by risk group, 1990-2019: A population-based cohort study in British Columbia, CanadaAmit K Gupta, Aidan Ablona, Theodora B Consolacion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survivalYanhong Liu, Sanjay Shete, Carol J Etzel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with afliberceptJohn F de Groot, Yuji Piao, Hai Tran, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Process monitoring of an HIV treatment as prevention program in British Columbia, CanadaLillian Lourenço, Viviane D Lima, Kate Heath, et al.
Journal of Neuro-Oncology|February 26, 2020
The prevalence of altered body image in patients with primary brain tumors: an understudied populationLindsay Rowe, Elizabeth Vera, Alvina Acquaye, et al.
Clinical Epidemiology|September 15, 2018
Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individualsZahid A Butt, Nabin Shrestha, Dionne Gesink, et al.
Journal of Neuro-Oncology|July 20, 2002
An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitisKurt A Jaeckle, Tracy Batchelor, Steven J O'Day, et al.
Pageof 25